Harvard Medical School researchers at Boston Children's Hospital and Dana-Farber Cancer Institute have identified a new pathway that regulates the production of fetal hemoglobin, a form of hemoglobin that normally gets replaced soon after birth by adult hemoglobin.
❓ Unknown
New Pathway Identified for Treating Sickle Cell Disease and Beta Thalassemia
Just now
September 30, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
Researchers at Harvard Medical School, Boston Children's Hospital, and Dana-Farber Cancer Institute have discovered a new pathway that regulates fetal hemoglobin production, which could lead to advancements in treating sickle cell disease and beta thalassemia. This research is significant as these diseases are prevalent in Iran, affecting many individuals and families. Improved treatments could alleviate the healthcare burden in the country.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
8 min ago •
Brigadier General Tehrani-Moghadam: The Enemy Will Face Unprecedented Response in Ground War
10 min ago •
Trump's Statements on U.S. Withdrawal from Iraq
11 min ago •
Over 2,000 Visits Recorded in the '100 Nights, 100 Visits' Initiative in Ahvaz/ Need for…
14 min ago •
Russia Summons Danish Ambassador
15 min ago •